alexa Gruzman A | Bar-Ilan University
ISSN: 2157-7439

Journal of Nanomedicine & Nanotechnology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Gruzman A

Department of Chemistry, Bar-Ilan University, Israel

Dr. Arie Gruzman is a Senior Lecturer at the Department of Chemistry, Bar-Ilan University, since 2009.  Arie Gruzman received his B.Sc. in Medicinal Chemistry from Bar-Ilan University and Ph.D. (cum laude) in Pharmacology/Medicinal Chemistry from the Pharmacy School, Faculty of Medicine, of the Hebrew University. Between 2003-2007, he was a post-doctoral fellow at the Department of Physiology, Medical School, at UCSF and in the California Pacific Medical Center Research Institute. Dr. Gruzman is the coauthor of 30 publications in refereed journals, 4 patents and over 20 papers in international conference proceedings.

Research Interest

Dr. Arie's research focuses on development of novel drugs against diabetes, ALS and cancer.


Gene Silencing by siRNA Nanoparticles Synthesized via Sonochemical Method

Shimanovich U, Munder A, Loureiro A, Azoia NG, Gomes A, Cavaco-Paulo A, Gedanken A and Gruzman A

Research Article: J Nanomed Nanotechnol 2014, 5:204

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version